Search Results 1031-1040 of 16351 for pharmacogenetics
This clinical study is in subjects who are 18 years old or older with locally advanced pancreatic cancer who have not received prior treatment for their ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
ROCHESTER, Minn. — Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk ...
The purpose of this study is train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features. Participation ...
ROCHESTER, Minn. — Mayo Clinic has been selected to lead a groundbreaking research project focused on improving indoor air quality and safety in healthcare ...
Priorello LJ, Sperry JA, Yee CI, Kapoor S, Patchett DC, Townsend CO. Pilot study of an integrative telehealth group intervention for chronic pain.
Researchers Improve AI Models Used in Drug Discovery featured image · Research · Patients with mitral annulus calcification at higher risk of heart valve and ...
LQTS is a genetic heart disease that can potentially cause fast, chaotic heartbeats. These rapid heartbeats might trigger people to faint suddenly. Some people ...
About this study. This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.